In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Baxter International’s current price exceeds its PERT-weighted fair value by 12.7%, suggesting potential overvaluation. Monte Carlo analysis shows high volatility with 75% downside risk and a median valuation below current price, reflecting substantial uncertainty. Weak profitability and growth scores contrast with strong liquidity, highlighting financial vulnerability despite stable cash availability.